Victory Capital Management’s Impax Laboratories, Inc. IPXL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q1 | – | Sell |
-1,274,813
| Closed | -$16.9M | – | 1902 |
|
|
2016
Q4 | $16.9M | Buy |
1,274,813
+36,023
| +3% | +$477K | 0.04% | 606 |
|
|
2016
Q3 | $29.4M | Buy |
1,238,790
+217,142
| +21% | +$5.15M | 0.08% | 433 |
|
|
2016
Q2 | $29.4M | Buy |
1,021,648
+91,958
| +10% | +$2.65M | 0.12% | 302 |
|
|
2016
Q1 | $29.8M | Buy |
929,690
+423,452
| +84% | +$13.6M | 0.12% | 294 |
|
|
2015
Q4 | $21.6M | Sell |
506,238
-9,336
| -2% | -$399K | 0.09% | 372 |
|
|
2015
Q3 | $18.2M | Buy |
515,574
+18,965
| +4% | +$668K | 0.07% | 412 |
|
|
2015
Q2 | $22.8M | Sell |
496,609
-141,869
| -22% | -$6.51M | 0.08% | 380 |
|
|
2015
Q1 | $29.9M | Buy |
638,478
+57,843
| +10% | +$2.71M | 0.11% | 327 |
|
|
2014
Q4 | $18.4M | Buy |
+580,635
| New | +$18.4M | 0.07% | 426 |
|